Godavari Drugs has informed that it submitted the Statement on Deviation or Variation in utilisation of funds for the quarter ended 30 June 2026. The aforesaid Statement was considered and approved by the Board of Directors of the Company at its meeting held on 14 August 2026 and the same has been filed with the Stock Exchange along with the outcome of the said Board Meeting on 14 August 2026.
The above information is a part of company’s filings submitted to BSE.